Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Epilepsy × Ketamine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 10 Neoplasms 10 Pain, Postoperative 9 Agnosia 8 Depression 7 Breast Neoplasms 7 Head and Neck Neoplasms 5 Chronic Pain 4 Anxiety Disorders 4 Pancreatic Neoplasms 3 Pain, Intractable 3 Colorectal Neoplasms 3 Acute Pain 3 Prostatic Neoplasms 2 Gastrointestinal Neoplasms 2 Cancer Pain 2 Stomatitis 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Analgesia 1 Peripheral Nervous System Diseases 1 Pelvic Neoplasms 1 Pain, Procedural 1 Otolaryngeal Cancer 1 Neurotoxicity Syndromes 1 Mucositis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Laparoscopic Colorectal Resection Due to Cancer 1 Ileus 1

Interventions

Sirolimus 4 Everolimus 3 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07165262 2025-09-10

ECOG-Anaes

Children's Cancer Hospital Egypt 57357

Phase 3 Active not recruiting

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡